0001209191-19-012806.txt : 20190222 0001209191-19-012806.hdr.sgml : 20190222 20190222213234 ACCESSION NUMBER: 0001209191-19-012806 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190222 FILED AS OF DATE: 20190222 DATE AS OF CHANGE: 20190222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Peterson Kristine CENTRAL INDEX KEY: 0001508596 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21392 FILM NUMBER: 19627930 MAIL ADDRESS: STREET 1: AMARIN CORPORATION STREET 2: MYSTIC PACKER BLDG., 12 ROOSEVELT AVENUE CITY: MYSTIC STATE: CT ZIP: 06355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMARIN CORP PLC\UK CENTRAL INDEX KEY: 0000897448 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: FIRST FLOOR, BLOCK 3, THE OVAL, STREET 2: SHELBOURNE ROAD, BALLSBRIDGE CITY: DUBLIN STATE: L2 ZIP: 00000 BUSINESS PHONE: 353 1 6699 020 MAIL ADDRESS: STREET 1: FIRST FLOOR, BLOCK 3, THE OVAL, STREET 2: SHELBOURNE ROAD, BALLSBRIDGE CITY: DUBLIN STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: AMARIN PHARMACEUTICALS PLC DATE OF NAME CHANGE: 20000201 FORMER COMPANY: FORMER CONFORMED NAME: ETHICAL HOLDINGS PLC DATE OF NAME CHANGE: 19930322 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-22 0 0000897448 AMARIN CORP PLC\UK AMRN 0001508596 Peterson Kristine C/O AMARIN PHARMA, INC. 1430 ROUTE 206 BEDMINSTER NJ 07921 1 0 0 0 Ordinary Shares 2019-02-22 4 M 0 120000 3.67 A 120000 D Ordinary Shares 2019-02-22 4 M 0 30000 14.40 A 150000 D Ordinary Shares 2019-02-22 4 M 0 13500 5.58 A 163500 D Ordinary Shares 2019-02-22 4 S 0 163500 20.0247 D 0 D Stock Option (Right to Buy) 3.67 2019-02-22 4 M 0 120000 0.00 D 2020-11-17 Ordinary Shares 120000 0 D Stock Option (Right to Buy) 14.40 2019-02-22 4 M 0 30000 0.00 D 2022-07-20 Ordinary Shares 30000 0 D Stock Option (Right to Buy) 5.58 2019-02-22 4 M 0 13500 0.00 D 2023-07-08 Ordinary Shares 13500 0 D The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The stock option granted to the Reporting Person is fully vested as of the date hereof. /s/ Joseph Kennedy, by power of attorney 2019-02-22